Quetiapine and Neuroleptic Malignant Syndrome

Hasan S Buckley P. Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique. Am J Psychiatry 1998;155:1113–6.

Gheorghiu S Knobler H Drumer D. Recurrence of neuroleptic malignant syndrome with olanzapine treatment. Am J Psychiatry 1999;156:1836–7.

Gefvert O Bergstrom M Langstrom B Lundberg T Lindstrom L Yates R. Time course of central nervous dopamine-D2 and 5HT2 receptor blockade and plasma concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. Psychopharmacology 1998;135:119–26.

Targum SD Arvantis LA . Quetiapine: Efficacy, safety, and tolerability in elderly subject with psychotic disorders. Psychopharmacology Bulletin 1997;33:596.

Al-Waneen R. Neuroleptic malignant syndrome associated with quetiapine [letter]. Can J Psychiatry 2000;45:764.

Stanley AK Hunter J. Possible neuroleptic malignant syndrome with quetiapine. Br J Psychiatry 2000;176:497.

Whalley N Diaz P Howard J. Neuroleptic malignant syndrome associated with the use of quetiapine. Can J Hospital Pharmacy 1999;52:112.

Sachdev P Kruk J Kneebone M Kissane D. Clozapine-induced neuroleptic malignant syndrome: Review and report of new cases. J Clin Psychopharmacol 1995;15:365–71.